Biochip Langdao (Tianjin) Medical Technology Limited
🇨🇳 China
202311-50 peopleManufacturer
High-tech enterprise
Patented technology
Own brand
Low MOQ
Description
Biochip Langdao (Tianjin) Medical Technology Limited is an R&D-based biotechnology manufacturer based in Tianjin, China, specializing in in vitro diagnostics, medical devices, and medical products for public health. Established in 2023, the company is recognized as a National High-tech Enterprise and employs 11 to 50 people. They offer OEM services and operate a factory with three production lines. Their core offerings include POCT devices, immunoassay analyzers, and in vitro diagnostic reagents. A key product is their patented strip-based fully automatic chemiluminescence immunoassay analyzer, CLite-160I, for which they have developed 12 NMPA and CE certified testing reagents covering myocardial, inflammatory, and gastritis biomarkers. They also produce medical equipment, disinfectants, and personal care products in various forms, including the "Well-Fit" Anti-allergy nasal barrier gel and oral antibacterial sprays. The company holds NMPA and CE certifications for its products and owns the registered trademarks "Biochip Langdao" and "Well-Fit".
MD Pacific (Tianjin) Biotechnology Co., Ltd. is a prominent high-tech enterprise and manufacturer specializing in in vitro diagnostic (IVD) products, medical diagnostic instruments, and biotherapy ancillary products. Established in 2003 and based in the Binhai New Area of Tianjin, China, the company operates as a joint venture with Chinese, American, and German interests. With a workforce of 101 to 200 employees, the firm maintains a strong focus on research and development, supported by a postdoctoral scientific research station and 38 patents.